For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Free the Economy podcast: Paying for organs with Pete Jaworski
In this week’s episode we cover the future of AI and employment, why we shouldn’t trust Chinese economic statistics, and how the…
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
Blog
This week in ridiculous regulations: Taconite and lab fees
President Biden delivered his State of the Union address. Super Tuesday primaries all but settled this year’s presidential combatants. The FTC has a full slate…
Search Posts
The New York Post
Biden Wastes Billions on COVID Boosters No One Wants
When it comes to wasting money, the Biden administration has few peers. Earlier in the year, Team Biden re-purposed billions of dollars to buy 170…
The New York Post
Team Biden’s Extending the COVID Emergency Again — to Expand the Welfare State
It’s official. Despite President Biden’s recent admission that the pandemic is over, his team will extend the COVID-19 public health emergency through at least April…
The New York Post
Team Biden’s Latest Welfare Expansion: Medicaid Payments for Housing, Food, even Furniture
Co-authored by Dr. Joel Zinberg and Gary Alexander The latest front in the Biden administration’s crusade to bypass the congressional appropriations process and expand the…
National Review
The CDC’s Premature Childhood-Vaccine Decision
The Centers for Disease Control and Prevention has proven once again how tone-deaf it is. The CDC’s independent Advisory Committee on Immunization Practices (ACIP) voted 15–0…
Wall Street Journal
The Bivalent Booster Boondoggle
The public-health bureaucracy is adopting yet another excessive vaccination policy. On Oct. 12 the Food and Drug Administration authorized bivalent Covid-19 boosters from …
Wall Street Journal
The Bivalent Booster Boondoggle
The public-health bureaucracy is adopting yet another excessive vaccination policy. On Oct. 12 the Food and Drug Administration authorized bivalent Covid-19 boosters from …